Product Information

BUSPIRONE HCL 30 MG TABLET is a generic product labeled by Mylan Institutional LLC, priced at $0.1237 per EA under NDC 51079099420. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Mar 28, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUSPIRONE HCL 30 MG TABLET

buspirone hydrochloride
$0.1237per EA

Strength

30 mg/1

NDC

51079099420

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUSPIRONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA076008

FDA Approved

3/28/2001

TE Code

AB

On Market Since

12/1/2002

Price Statistics

The NADAC for BUSPIRONE HCL 30 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 79.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1237 per EA
All-time high$0.6324 (Jan 15, 2014)
All-time low$0.0971 (May 22, 2024)
52-week high$0.1237
52-week low$0.1098
Median price$0.2599
Average price$0.3042
Largest weekly change+36.0% (Jun 19, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+0.6%

1M

+3.2%

3M

+4.2%

6M

+10.7%

1Y

+8.2%

3Y

+5.1%

5Y

-40.0%

All

-79.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUSPIRONE HCL 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 30 MG TABLET, manufactured by Mylan Institutional LLC, is $0.1237 per EA (NDC 51079099420), effective Nov 18, 2026.

How has the price of BUSPIRONE HCL 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUSPIRONE HCL 30 MG TABLET has declined 79.9%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 30 MG TABLET?

Since Nov 28, 2013, the NADAC for BUSPIRONE HCL 30 MG TABLET has ranged from a low of $0.0971 (May 22, 2024) to a high of $0.6324 (Jan 15, 2014), with a median of $0.2599 per EA.

Are there cheaper alternatives to BUSPIRONE HCL 30 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 30 MG TABLET, is $0.1198 per EA — about 3% below BUSPIRONE HCL 30 MG TABLET.

Who manufactures BUSPIRONE HCL 30 MG TABLET?

BUSPIRONE HCL 30 MG TABLET (NDC 51079099420) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.